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Background: Coffee and its compounds have been proposed to inhibit endometrial carcinogenesis. Studies in the
Norwegian population can be especially interesting due to the high coffee consumption and increasing incidence
of endometrial cancer in the country.
Methods: A total of 97 926 postmenopausal Norwegian women from the population-based prospective Norwegian
Women and Cancer (NOWAC) Study, were included in the present analysis. We evaluated the general association
between total coffee consumption and endometrial cancer risk as well as the possible impact of brewing method.
Multivariate Cox regression analysis was used to estimate risks, and heterogeneity tests were performed to compare
brewing methods.
Results: During an average of 10.9 years of follow-up, 462 incident endometrial cancer cases were identified.
After multivariate adjustment, significant risk reduction was found among participants who drank ≥8 cups/day
of coffee with a hazard ratio of 0.52 (95% confidence interval, CI 0.34-0.79). However, we did not observe a
significant dose-response relationship. No significant heterogeneity in risk was found when comparing filtered
and boiled coffee brewing methods. A reduction in endometrial cancer risk was observed in subgroup analyses
among participants who drank ≥8 cups/day and had a body mass index ≥25 kg/m2, and in current smokers.
Conclusions: These data suggest that in this population with high coffee consumption, endometrial cancer risk
decreases in women consuming ≥8 cups/day, independent of brewing method.
Keywords: Coffee, Brewing method, Endometrial cancer risk, Norway, High coffee consumption, Prospective
cohort studyBackground
Endometrial cancer comprises about 4% of all cancers in
women globally and occurs predominantly after meno-
pause [1]. Some of the highest incidence rates worldwide
are found in European populations [2], and a consistent
increase in incidence has been observed in the Nordic
countries [3]. Although the exact cause of this increase* Correspondence: oxana.gavrilyuk@uit.no
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unless otherwise stated.is unknown, use of postmenopausal estrogen therapy
and exposure to high levels of obesity-related hormones
(i.e. estrogen and insulin) may be contributing factors [4,5].
Recently, a growing number of studies have highlighted
that coffee, one of the most consumed beverages in the
world, may favorably alter hormone levels [6-9] and conse-
quently lower endometrial cancer risk [10,11]. Coffee
might also decrease endometrial cancer risk due to its anti-
oxidant properties [12,13] and capability to prevent DNA
damage [14]. Interestingly, coffee contains numerous active
substances, such as caffeine, diterpenes, chlorogenic acidsal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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coffee compounds vary by coffee type (e.g. caffeinated
or decaffeinated) and might also be modified by differ-
ent preparations/brewing methods (e.g. boiled or filtered)
[15,16]. Although traditions concerning coffee types and
brewing methods, and levels of coffee consumption may
vary across populations, relatively few countries have in-
vestigated the association between specific coffee con-
sumption and endometrial cancer risk.
Two recent prospective studies showed inconsistent
results concerning the association between coffee type
and endometrial cancer risk. While one study [17] found
a significant decrease in risk associated with only caf-
feinated coffee in obese women, another [18] concluded
that both caffeinated and decaffeinated coffee may re-
duce endometrial cancer risk. Overall, it is unclear
whether caffeine is the compound causally associated
with endometrial cancer risk reduction. Moreover, to the
best of our knowledge, only one Swedish prospective
study has investigated the effect of boiled and filtered
coffee on endometrial cancer risk [19]. Although chem-
ical analyses in several reports showed that filtration
leads to an almost complete removal of diterpenes, the
most promising chemopreventive compounds in coffee
[16], the comparison of filtered and boiled coffee in the
Swedish study did not reveal any differences between
these brewing methods and endometrial cancer risk. Of
note, results from the Swedish study were inconsistent
with previous studies and found no significant effect of
coffee consumption on endometrial cancer risk. Thus, it
remains unclear what role, if any, different brewing
methods or coffee types play when it comes to endomet-
rial cancer risk.
Norway has the second largest coffee consumption per
capita after Finland, including a long tradition of using
different brewing methods [20,21]. Therefore our large
prospective study based on a representative sample of
the general Norwegian female population offers a unique
opportunity to investigate the effect of high coffee con-
sumption covering different brewing methods, including
boiled and filtered, on the incidence of postmenopausal
endometrial cancer, which is steadily increasing in Norway
(about 700 new cases registered annually) [22].
Methods
The NOWAC cohort
Using the unique 11-digit personal identity number
assigned to all people legally residing in Norway (citizens,
those with temporary work permission, refugees, etc.), a
random sample of women aged 30–70 years was chosen
from the Central Population Registry of Norway and sent
an invitation to participate in the Norwegian Women and
Cancer (NOWAC) Study [23,24]. Linkage was then per-
formed with the Central Population Registry to obtainpostal addresses and vital status (alive, emigrated or de-
ceased) of women. Linkage with the Cancer Registry of
Norway was also performed to determine cancer inci-
dence until December 31, 2009. The NOWAC Study is
a large population-based cohort study, aim of which is
to prospectively examine the associations between dif-
ferent lifestyle factors and the risk of various diseases in
a representative sample of the general Norwegian fe-
male population [24]. Between 1991 and 2010, a total
of 172 000 women were enrolled in the NOWAC
Study. As part of their participation they completed a
self-administered questionnaire on lifestyle, health and
diet.
Study sample
The present analysis used information taken from base-
line questionnaires collected from NOWAC participants
enrolled in 1991–1997 and 2003–2007 (129 854 women
out of 239 388 invited, response rate 54.2%). Of these
129 854 women, we selected those who were either post-
menopausal at start of follow-up, or who became post-
menopausal during the course of follow-up. We excluded
2938 women with prevalent cancer at enrollment, 543
women who died before reaching menopause, 38 women
with missing follow-up information on vital status and
migration status, 6544 women who had hysterectomy
at enrollment, 17 women who developed incident uter-
ine sarcoma during follow-up, 7085 women with miss-
ing information on covariates, and 3090 premenopausal
women (premenopausal at enrollment and throughout
follow-up). We also excluded 11 673 women with miss-
ing information on coffee consumption. The final study
sample included in the analyses consisted of 97 926
postmenopausal women at start of follow-up. All
women provided informed consent, and the study was
approved by The Regional Committee for Medical
Research Ethics and the Norwegian Data Inspectorate.
Dietary assessment
Year of enrollment determined the version of the ques-
tionnaire that participants completed, therefore women
were asked about either their total coffee consumption
(total coffee version of the questionnaire), or their con-
sumption of filtered, boiled, and instant coffee separately
(brewing method version of the questionnaire). The cat-
egories of coffee consumption were also different in two
versions of the questionnaire. In the total coffee con-
sumption version, women were asked to choose from one
of the following responses: 6–10 cups/day, 4–5 cups/day,
2–3 cups/day, 1 cup/day, 5–6 cups/week, 2–4 cups/week,
1 cup/week, 1–3 cups/month, and almost never. However,
in the brewing method version, women could also choose
from the following responses: ≥8 cups/day, 6–7 cups/day,
4–5 cups/day, 2–3 cups/day, 1 cup/day, 1–6 cups/week,
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alternatives. Therefore, in our analysis we had to create
a common version of frequencies for both the total cof-
fee version and the brewing method version of the
questionnaire. Therefore we collapsed the categories of
lowest consumption from both versions of the ques-
tionnaire (1 cup/day, 5–6 cups/week, 2–4 cups/week,
1–6 cups/week, 1 cup/week, 1–3 cups /month and al-
most never) into a single category (≤1 cup/day), which
was used as the reference in all analyses. The final cat-
egories used in the analysis were: ≤1 cup/day (reference
category), 2–3 cups/day, 4–7 cups/day and ≥8 cups/day
(heavy consumers). Participants who responded 6–10
cups/day in the total coffee questionnaire were catego-
rized as ≥8 cups/day in the final categories. About 13%
of the study population had missing values on brewing
methods.
The size of a cup of coffee was not determined in the
questionnaire, but we chose to use 2.1 dl (7.1 oz) as the
standard cup size, based on a 24-hour recall investigation
in the NOWAC cohort (data not shown). The NOWAC
Study Food Frequency Questionnaire (FFQ) has been thor-
oughly validated by 24-h recalls [25] and a test-retest study
[26], which showed good reproducibility and validity of
information on coffee consumption (Spearman’s rank cor-
relation coefficient r = 0.82, 95% confidence interval, CI
0.77-0.86; calibration coefficient 1.17, 95% CI 1.06-1.28).
Assessment of lifestyle factors
Information on age at inclusion, age at menarche, age at
first birth, education level, duration of oral contraceptive
use, hormone replacement therapy use (current, former,
never), smoking status (current, former, never), physical ac-
tivity, and current weight and height were collected from
questionnaire at enrollment. Body mass index (BMI) was
calculated as weight in kg divided by height in meters
squared. Menopausal status was updated when information
was available. Women who were premenopausal at enroll-
ment, but whose menopausal status changed to postmeno-
pausal during follow-up contributed to the study as from
the date they became postmenopausal. Menopausal status
was derived from the answers to questions on menstru-
ation regularity in the questionnaires. If women reported
that their menstruation was regular, they were considered
premenopausal. Women were classified as postmenopausal
if they reported that their menstruation had stopped at the
time of enrollment or during the follow-up. In case of un-
certain menstruation regularity (irregular, hysterectomy,
hormone replacement therapy use or otherwise insufficient
information), women were defined as postmenopausal if
they were at least 53 years old at the time of enrollment, or
once they turned 53 during follow-up. This cut-off point
has been used in previous NOWAC reports [23], based on
the definition employed in The Million Women Study [27].Ascertainment of endometrial cancer cases
Information on cancer incidence among NOWAC
Study participants was obtained by yearly linkage to the
Norwegian Cancer Registry based on the unique 11-digit
person identification number assigned to each Norwegian
legal resident and citizen. By the end of the follow-up
period, 462 incident endometrial cancer cases were re-
corded in our study sample.
Statistical analysis
Follow-up of participants started at age of enrollment in
the NOWAC Study (1991-1997, 2003–2007) or at age at
menopause (for those women who were premenopausal
at enrollment). Women were censored at the date of
diagnosis of endometrial cancer, date of death or immi-
gration, date of report of any other cancer, or the end of
follow-up (31 December 2010). Cox proportional hazard
regression models were used to estimate the hazard ra-
tios (HRs) of developing endometrial cancer with 95%
CIs in each category of coffee consumption compared
with consumers in the lowest category of consumption
(≤1 cup/day). We were unable to use coffee abstainers
(non-consumers) as a reference group as we had too few
endometrial cancer cases in the groups of only boiled
and only instant coffee drinkers (Table 1). The variable
total coffee consumption included responses to total cof-
fee consumption (from total coffee version of the ques-
tionnaire) or a combination of responses to boiled, filtered
and instant coffee consumption (from the brewing
method version of the questionnaire). As there were very
few heavy consumers of instant coffee (n = 2), we did not
investigate the effect of instant coffee consumption when
estimating risk stratified by brewing method. However, in-
stant coffee consumption was included in total coffee con-
sumption. A test of the proportional hazard assumption
was checked graphically and by assessment of Schoenfeld
residuals for all relevant variables.
To test for trends, we looked at the percentage points
of risk reduction conferred by each additional cup of
coffee consumed when consumption was coded as a
continuous variable or we assigned a median value to
each category of coffee consumption when coded as a
categorical variable. Multivariate analyses were carried
out to control for the potential confounding effects of
age at first birth, parity, age at menopause, oral contra-
ceptive use, hormone replacement therapy use, smoking
status, and BMI. We assessed the heterogeneity in ef-
fects between different brewing methods by Wald tests.
Because of the proposed modifying role of BMI and
smoking status, we performed subgroup analyses esti-
mating the risk conferred by total coffee consumption
on endometrial cancer stratified by these factors al-
though we did not find any significant interaction be-
tween total coffee consumption and smoking (p = 0.72)



















n = 97 926 n = 93 858 n = 32 049 n = 93 858 n = 60 025 n = 93 858 n = 22 501
≤ 1 cups per day 16.1 80.0 54.4 40.1 25.6 91.7 77.5
2-3 cups per day 32.9 7.9 16.1 25.9 30.4 5.4 13.3
4-7 cups per day 37.8 8.4 20.2 25.9 33.4 2.4 7.5
≥ 8 cups per day 13.2 3.7 9.3 8.1 10.6 0.5 1.7
No of cases n = 462 n = 452 n = 174 n = 452 n = 322 n = 452 n = 112
≤ 1 cups per day 17.7 77.9 51.2 44.2 27.6 92.7 79.5
2-3 cups per day 37.1 10.4 21.8 27.0 34.2 4.6 10.7
4-7 cups per day 38.3 10.2 23.0 25.0 32.9 2.3 8.0
≥ 8 cups per day 6.9 1.5 4.0 3.8 5.3 0.4 1.8
aTotal coffee is combination of responses on total coffee consumption in the total coffee version of the questionnaire and filtered, boiled and instant coffee
consumption in the brewing methods version of the questionnaire. bCombined with other types: those women who positively responded to question about
“total coffee consumption” or/and other brewing method (filtered, boiled, instant).
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also performed analyses in which boiled and filtered cof-
fee were adjusted for each other, using coffee consump-
tion as both a categorical and a continuous variable.
All analyses were conducted using SAS for Windows
(version 9.2; SAS Institute Inc., Cary, North Carolina,
USA). All tests were two-sided with statistical signifi-
cance set at p < 0.05.
Results
Distribution of NOWAC participants and baseline
characteristics
Participants who answered on brewing method version
of the questionnaire were divided into two subgroups:
those who consumed coffee prepared by only one brew-
ing method (boiled, filtered, or instant) and those who
used a mixture of brewing methods.
Among all coffee consumers, women with total coffee
consumption of 2–3 cups/day and 4–7 cups/day repre-
sented the largest groups (32.9% and 37.8%, respect-
ively). Although women drinking only filtered coffee also
mostly reported to drink between 2–7 cups/day women
drinking only boiled coffee appear to consume less with
54.4% drinking ≤1 cup/day (Table 1). In the group that
we classified as non-consumers, there was a substantial
proportion of women who were actually instant coffee
drinkers in very small quantities (91.7% of participants
in the group of ≤1 cup/day).
Table 2 shows the distribution of known risk factors
and main baseline characteristics of our study cohort ac-
cording to total coffee consumption. Women with a
higher total coffee consumption had lower age at enroll-
ment, at menarche, at first birth and at menopause, wereless often nulliparous, were more often current smokers,
and were leaner than women with lower coffee consump-
tion. This tendency was observed within all brewing
methods. During an average of 10.9 years of follow-up,
462 cases of incident endometrial cancer were diagnosed
in 97 926 women, contributing 1 071 943 person-years of
observation. The mean age at diagnosis of endometrial
cancer was 61.5 years (Table 2).
Endometrial cancer risk
A statistically significant inverse association between
total coffee consumption and endometrial cancer risk
was observed among heavy consumers (age-adjusted HR
0.44, 95% CI 0.29-0.67) (Table 3). This association was
slightly attenuated after multivariate adjustment (HR
0.52, 95% CI 0.34-0.79).
When analyzing different brewing methods, there was
an inverse association among heavy consumers of fil-
tered coffee only and heavy consumers of filtered coffee
combined with other coffee brewing methods (multivari-
ate-adjusted HR 0.55, 95% CI 0.32-0.94 and HR 0.55,
95% CI 0.33-0.91 respectively). However, when fre-
quency of filtered coffee consumption was analyzed as a
continuous variable, no significant dose-response rela-
tionship was observed for filtered coffee alone (p for
trend 0.07), or for filtered coffee combined with other
brewing methods (p for trend 0.12). In boiled coffee
drinkers we observed a significant inverse association
only among heavy consumers (age-adjusted HR 0.42,
95% CI 0.19-0.91), but this inverse association was bor-
derline significant after multivariate adjustment (HR
0.45, 95% CI 0.21-1.01). We did not observe any signifi-
cant dose-response relationship when boiled coffee
Table 2 Baseline characteristics of postmenopausal NOWAC Study participants according to total coffee consumption
Characteristics Average total coffee consumption, cups per day
≤ 1 2-3 4-7 ≥ 8
Number of women (%) 15795 (16.1) 32200 (32.9) 36992 (37.8) 12939 (13.2)
Number of EC cases (%) 82 (17.7) 171 (37.1) 177 (37.8) 32 (6.9)
Mean (sd)
Age at enrollment, years 47.5 (8.64) 48,7 (8.73) 47.9 (8.31) 43.7 (6.82)
Age at menarche, years 13.4 (1.45) 13.4 (1.37) 13.3 (1.36) 13.2 (1.39)
Age at first birth, years 24.8 (4.53) 24.4 (4.39) 23.6 (4.17) 22.7 (3.99)
Age at menopause, years 48.1 (5.03) 48.7 (8.74) 48.3 (4.66) 46.9 (4.95)
Duration of OC use, years 2.9 (4.56) 2.6 (4.29) 2.5 (4.12) 2.6 (4.01)
Number of children, %
0 11.4 9.5 7.9 7.5
1-2 55.4 53.9 52.6 53.5
≥ 3 33.2 36.6 39.5 39.0
Years of total education, %
< 9 16.6 21.2 28.9 36.7
10-12 30.2 33.3 36.3 38.3
13-16 32.5 29.9 24.3 19.3
> 17 20.8 15.6 10.5 5.9
Smoking status, %
Current 17.7 21.8 39.3 61.8
Former 31.1 35.6 31.9 24.6
Never 51.2 42.6 28.8 13.7
BMI, %
< 20 10.1 8.1 7.9 10.9
20-24.9 56.8 58.1 56.7 57.6
25-29.9 24.3 26.7 28.3 24.8
≥ 30 8.8 7.1 7.0 6.8
HRT use, %
Never 79.7 79.9 83.3 91.1
Former 8.7 8.4 7.1 3.3
Current 11.6 11.7 9.7 5.6
Prevalence of diabetes, % 0.98 0.82 0.92 0.98
Abbreviations: NOWAC Norwegian Women and Cancer, EC Endometrial cancer, SD Standard deviation, OC Oral contraceptives, BMI Body mass index, HRT Hormone
replacement therapy.
N = 97 926.
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other brewing methods were included as continuous var-
iables (p for trend 0.07 and 0.36 respectively).
Since BMI is a strong risk factor for endometrial cancer,
and smoking has been reported to alter caffeine clearance,
we examined additional effect modification by stratifying
analyses by brewing method, BMI (<25 and ≥25, which is
considered overweight) and smoking status (never, former,
current). Total coffee consumption was significantly in-
versely associated with endometrial cancer only amongoverweight women who were heavy total coffee con-
sumers or heavy consumers of filtered coffee (multivari-
ate-adjusted HR 0.39, 95% CI 0.21-0.73 and HR 0.46, 95%
CI 0.22-0.96, respectively) (Table 4). There was a signifi-
cant reduction in endometrial cancer risk among current
smokers who were heavy total coffee consumers (multi-
variate-adjusted HR 0.36, 95% CI 0.17-0.79). However, the
association between smoking and endometrial cancer risk
in relation to different brewing methods did not reach
statistical significance, which could be due to limited
Table 3 HRs and 95% CIs of endometrial cancer related to total, filtered and boiled coffee among 97 926
postmenopausal NOWAC Study participants
No of cups Total coffeea Boiled coffee Filtered coffee
Combined with other typesb Only boiled coffee Combined with other types Only filtered coffee
Age-adjusted HR, CI 95%c
≤ 1 cups/day 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
2-3 cups/day 0.87 (0.67-1.13) 1.12 (0.83-1.53) 1.03 (0.70-1.51) 0.98 (0.79-1.23) 0.93 (0.70-1.23)
4-7 cups/day 0.76 (0.59-0.99) 1.06 (0.78-1.44) 0.87 (0.59-1.26) 0.89 (0.71-1.13) 0.79 (0.60-1.06)
≥ 8 cups/day 0.44 (0.29-0.67) 0.43 (0.2-0.91) 0.42 (0.19-0.91) 0.48 (0.29-0.79) 0.45 (0.26-0.75)
p for trend < 0.0001 0.21 0.02 0.002 0.03
Multivariate-adjusted HR, CI 95%d
≤ 1 cups/day 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
2-3 cups/day 0.91 (0.70-1.19) 1.08 (0.79-1.46) 1.04 (0.71-1.54) 0.99 (0.79-1.24) 0.99 (0.75-1.31)
4-7 cups/day 0.84 (0.65-1.1) 1.10 (0.81-1.50) 0.92 (0.62-1.36) 0.95(0.76-1.20) 0.91 (0.68-1.21)
≥ 8 cups/day 0.52 (0.34-0.79) 0.48 (0.23-1.03) 0.45 (0.21-1.01) 0.55 (0.33-0.91) 0.55 (0.32-0.94)
p for trend 0.003 0.36 0.07 0.12 0.07
aTotal coffee is combination of responses on total coffee consumption in the total coffee version of the questionnaire and filtered, boiled and instant coffee
consumption in the brewing methods version of the questionnaire. bCombined with other types: those women who positively responded to question about
“total coffee consumption” or/and other brewing method (filtered, boiled, instant). cBasic model that was adjusted for age. dMultivariate model that was adjusted
for parity, smoking status, BMI, duration of OC and HRT use. Abbreviations: HR Hazard ratio, CI Confidence interval, NOWAC Norwegian Women and Cancer,
BMI Body mass index, OC Oral contraceptives, HRT Hormone replacement therapy.
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mellitus, physical activity and hormone replacement ther-
apy use was hampered by small numbers. Nevertheless,
when analyses were restricted to non-diabetic women, re-
sults were similar to those from the entire study sample.
To eliminate the potential effects of early undiagnosed
endometrial cancer, we repeated our analysis, excluding
endometrial cancer diagnosed during the first year of
follow-up. Results from this analysis did not differ from
those for the entire cohort. Adjusting one coffee brewing
method by another method did not affect any of the risk
analyses (Additional file 1: Table S1). No significant differ-
ences between boiled coffee and filtered coffee were found
(Additional file 2: Table S2).
Discussion
In this large population-based prospective study of post-
menopausal Norwegian women, total coffee consump-
tion was inversely associated with endometrial cancer
risk, whereas there were no significant differences in this
association by considered coffee brewing methods. The
inverse association was stronger among overweight
women, current smokers and heavy consumers. The
current results show an overall association between total
coffee consumption and endometrial cancer risk, which
corroborates the findings of recent prospective studies
[10,28-30] and supports the hypothesis that coffee and
its compounds may play an important role in the che-
moprevention of endometrial carcinogenesis.
There are several strengths in our study. The NOWAC
cohort is well-characterized with a large number ofparticipants who were randomly selected from the gen-
eral population, giving our study enough statistical
power to detect small differences in the studied sub-
groups. Lifestyle and dietary data were collected prior to
endometrial cancer diagnosis. This minimizes the risk of
recall bias, selection bias and reverse causation. In
addition, we had a broad range of exposures in the
cohort, and information on several coffee brewing
methods. To our knowledge this is the largest cohort
study to investigate the association between endometrial
cancer risk and boiled/filtered coffee consumption. Fi-
nally, our cohort was based in a population with strong
coffee consumption habits and low number of non-
consumers.
Our study also has some limitations, such as the self-
reporting of coffee consumption. Even though results
from both the NOWAC Study [25] and other studies
[31,32] have shown a satisfactory reproducibility and val-
idity of information on coffee consumption, various
biases may still arise when self-reported FFQs are used.
However, this kind of misclassification would most prob-
ably weaken the studied association, and would not lead
to significant bias. Other limitations are the lack of in-
formation on the newer types of coffee drinks that have
been incorporated into the Norwegian diet in the last
decade (e.g. cappuccino, mocha and latte), and the lack
of information about decaffeinated coffee, which, how-
ever, was rare in Norway during the enrollment periods.
Moreover, we lacked data on how coffee beans were
roasted, which can also influence the level and proper-
ties of some coffee compounds [16,33]. Finally, for a
Table 4 HRs and 95% CIs of total, boiled and filtered coffee consumption stratified by BMI and smoking status in 97
926 postmenopausal NOWAC Study participants
No of cups Age-adjusted HR, CI 95%a Multivariate-adjusted HR, CI 95%b
Total coffee Boiled coffee Filtered coffee Total coffee Boiled coffee Filtered coffee
BMI < 25 ≤ 1 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
2-3 0.93 (0.63-1.38) 0.88 (0.53-1.47) 1.29 (0.93-1.79) 0.96 (0.65-1.42) 0.87 (0.52-1.46) 1.25 (0.90-1.74)
4-7 0.78 (0.53-1.16) 0.88 (0.53-1.44) 1.05 (0.75-1.49) 0.86 (0.58-1.29) 0.97 (0.59-1.60) 1.11 (0.78-1.57)
≥ 8 0.54 (0.31-0.96) 0.50 (0.19-1.36) 0.57 (0.29-1.14) 0.65 (0.36-1.17) 0.59 (0.22-1.63) 0.66 (0.33-1.32)
p for trend 0.009 0.13 0.39 0.008 0.31 0.77
BMI≥ 25 ≤ 1 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
2-3 0.82 (0.57-1.17) 1.26 (0.85-1.85) 0.79 (0.58-1.09) 0.83 (0.58-1.19) 1.22 (0.83-1.80) 0.78 (0.57-1.08)
4-7 0.72 (0.51-1.02) 1.13 (0.77-1.67) 0.72 (0.51-1.02) 0.78 (0.55-1.12) 1.21 (0.82-1.79) 0.83 (0.60-1.13)
≥ 8 0.33 (0.18-0.61) 0.33 (0.10-1.02) 0.40 (0.19-0.83) 0.39 (0.21-0.73) 0.39 (0.12-1.23) 0.46 (0.22-0.96)
p for trend 0.0005 0.44 0.01 0.009 0.79 0.05
Never smokers ≤ 1 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
2-3 1.01 (0.7-1.44) 1.09 (0.72-1.67) 1.15 (0.85-1.57) 1.05 (0.74-1.51) 1.07 (0.70-1.62) 1.19 (0.87-1.62)
4-7 0.97 (0.67-1.41) 0.95 (0.57-1.58) 0.08 (0.76-1.53) 0.97 (0.67-1.42) 0.91 (0.55-1.53) 1.08 (0.76-1.53)
≥ 8 0.54 (0.23-1.26) 0.36 (0.05-2.52) 0.67 (0.25-1.83) 0.49 (0.21-1.16) 0.33 (0.05-2.33) 0.63 (0.23-1.72)
p for trend 0.41 0.59 0.99 0.26 0.44 0.94
Former smokers ≤ 1 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
2-3 0.75 (0.47-1.19) 1.05 (0.59-1.86) 0.69 (0.45-1.05) 0.76 (0.47-1.21) 1.04 (0.58-1.85) 0.70 (0.46-1.07)
4-7 0.76 (0.48-1.21) 1.79 (1.12-2.85) 0.79 (0.52-1.18) 0.74 (0.46-1.18) 1.69 (1.06-2.72) 0.77 (0.51-1.16)
≥ 8 0.59 (0.29-1.20) 0.25 (0.03-1.76) 0.66 (0.30-1.45) 0.57 (0.28-1.15) 0.23 (0.03-1.67) 0.64 (0.29-1.42)
p for trend 0.09 0.67 0.19 0.06 0.83 0.18
Current smokers ≤ 1 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
2-3 0.73 (0.37-1.45) 1.16 (0.56-2.41) 1.04 (0.60-1.78) 0.76 (0.38-1.52) 1.16 (0.56-2.42) 1.04 (0.60-1.79)
4-7 0.61 (0.32-1.15) 0.76 (0.39-1.48) 0.93 (0.58-1.50) 0.64 (0.34-1.21) 0.77 (0.39-1.50) 0.96 (0.59-1.55)
≥ 8 0.36 (0.17-0.79) 0.69 (0.28-1.73) 0.40 (0.17-0.95) 0.37 (0.17-0.81) 0.69 (0.28-1.73) 0.40 (0.17-0.95)
p for trend 0.009 0.30 0.12 0.01 0.30 0.13
aBasic model that was adjusted for age. bMultivariate model that was adjusted for parity, smoking status, BMI, duration of OC and HRT use. Abbreviations: HR Hazard
ratio, CI Confidence interval, BMI Body mass index, NOWAC Norwegian Women and Cancer, OC Oral contraceptives, HRT Hormone replacement therapy.
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on consumption of tea, cola-type drinks, and chocolate,
which contain some of the same possible bioactive com-
pounds as coffee, and therefore these variables could not
be adjusted for the present analysis.
Over the past two decades several studies have evalu-
ated the association between coffee consumption and
endometrial cancer risk. Only one prospective study
from Sweden has investigated the association between
two coffee brewing methods and endometrial cancer risk
[19] and did not find any significant decrease in endo-
metrial cancer risk associated with coffee consumption.
Our results support the main hypothesis of recent pro-
spective studies [10,28], which suggested a significant
inverse association with total coffee consumption, in par-
ticular among overweight women. However, these studies
reported a protective effect with moderate coffee consump-
tion (3–4 cups/day) [10,28], whereas we only observed thiseffect at high consumption levels (≥8 cups/day). This dis-
crepancy might be explained by the fact that Scandinavians
used to drink far more coffee than people in other coun-
tries [34,35]. Recent investigations from the National
Coffee Information Organization showed that in the period
1982–2009, which includes the enrolment period of the
NOWAC Study, 90% of Norwegians aged over 40 years
had an average coffee consumption of 4–5 cups/day [21].
It is possible that such a long tradition of heavy consump-
tion changed mechanisms involved in the association be-
tween coffee consumption and cancer risk. This hypothesis
however, needs further exploration. We cannot exclude the
possibility that coffee consumption reported at enrollment
decreases during follow-up for most participants.
There are several potential theories by which coffee
may reduce endometrial cancer risk. The hormonal the-
ory asserts that the metabolism of caffeine and other
coffee compounds interact mainly with the metabolism
Gavrilyuk et al. BMC Women's Health 2014, 14:48 Page 8 of 10
http://www.biomedcentral.com/1472-6874/14/48of estrogens. The oxidative metabolism of both caffeine
and estrogens are regulated by the same family of cyto-
chrome enzymes, and there is an interaction between
them [36-39]. In addition, the hormonal mechanism fo-
cuses on the ability of coffee to regulate several hormone
levels, the altered stimulation of which may lead to
hyperinsulinemia and, therefore, increased proliferation
of the endometrial stromal cells [40,41]. Thus, coffee in-
creases the level of adiponectin, the deficiency of which
leads to hyperinsulinemia [42], increases the level of free
estrogens by decreasing the level of sex hormone-
binding globulin (SHBG), and increases the level of cir-
culating free insulin-like growth factor-1 by decreasing
the levels of insulin-like growth factor-binding protein
[9]. Another theory suggests that coffee compounds
block the initiation phase of the carcinogenic process,
decrease DNA damage and protect cells against reactive
oxygen species by inducing the production of detoxifying
enzymes through several mechanisms [43,44].
The question about which bioactive compounds in cof-
fee have a higher antioxidant capacity remains open. Ex-
posure to these coffee components is highly dependent on
different conditions such as choice of beans and phase of
administration, and is most likely also dependent on brew-
ing method [16,33]. For a long time in Norway, boiled cof-
fee, which is prepared by boiling water and adding coarse
grounds in a pot, was the traditional brewing method.
However, since boiled coffee may increase cholesterol
levels [15], this brewing method was, to a large extent,
replaced by filtered coffee starting in the 1990s. Based
upon the market information from the National Coffee
Information Organization [21], Norway has been mostly
importing coffee Arabica, which is known to contain a
higher percentage of diterpenes, but a lower concentration
of caffeine in comparison to coffee Robusta [16]. In some
studies it was highlighted that use of different methods
and conditions can change the chemical composition of
coffee and therefore open opportunities to modify and de-
sign various coffee brews with desired beneficial health
effects [15]. Despite of this, we did not observe any signifi-
cant favorable differences in the brewing methods we con-
sidered in our report. On another note, the negative
effects of coffee drinking on health cannot be ignored. In-
deed, high amounts of boiled coffee may increase choles-
terol levels [45], although the beneficial effects of coffee
on health might be expected at consumption levels that
do not entail any increase in blood cholesterol [46].
In subgroup analyses, our data suggested that mecha-
nisms involving interactions with BMI and smoking may
be relevant in the association between coffee consump-
tion and endometrial cancer risk. Indeed, overweight
women with high coffee consumption have already been
reported to have stronger protection against endometrial
cancer in comparison to lean women [10,28]. This couldbe explained by the fact that obese women already have
lower levels of SHBG, resulting in higher levels of bio-
available estrogen, hypoadiponectinemia, insulin resist-
ance, hyperinsuliemia, and high levels of oxidative
stress [47], all of which have been reported to improve
in coffee drinkers [9,42]. It is also of interest that in our
study there was a strong significant inverse association
between coffee drinking and endometrial cancer risk
among women who were current smokers. These re-
sults are consistent with the results from a recently
published study [10], but the underlying mechanisms
are not fully understood. It is known that caffeine, nico-
tine and estrogens are metabolized by the same family
of cytochrome P450 enzymes [48,49]. As the half-life of
caffeine is much lower in smokers than non-smokers,
caffeine intake is usually higher in smokers. It was also
reported that smoking induces the 2-hydroxylation
pathway of estradiol metabolism, leading to decreased
bioavailability at estrogen target tissues. Thus, it was sug-
gested that caffeine in combination with nicotine en-
hances the clearance of estradiol by increasing CYP1A2
activity, and, hence, the combination of coffee drinking
and smoking might offer more pronounced protection
against hormone-dependent tumors [50]. In addition to
high BMI and smoking, some studies on the association
between endometrial cancer and coffee consumption have
reported a stronger association among never users, or at
least former users, of hormone replacement therapy
[10,28]. We did not observe any significant differences in
our subgroup analyses for ever and never users of hor-
mone replacement therapy but our analysis was hampered
by small numbers.
Conclusions
In conclusion, the findings of our study are in line with pre-
vious reports indicating that total coffee consumption may
decrease endometrial cancer risk. In addition, we found no
significant heterogeneity in risk when comparing different
brewing methods (filtered and boiled coffee). Because our
population generally has a high coffee consumption at inclu-
sion, the observed decreased endometrial cancer risk among
women consuming ≥8 cups/day should be considered with
caution. Thus, these findings need confirmation in other
populations with consistent heavy coffee consumption.
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